Vorinox 50 mg Tablet should be taken orally, once daily, with or without food. It is recommended to take it at the same time each day, preferably in the morning.

Vorisetin selectively inhibits the reuptake of serotonin (5-HT) into the presynaptic neuron, thereby increasing the concentration of 5-HT in the synaptic cleft. This leads to enhanced serotonergic neurotransmission and subsequent improvement in mood and anxiety symptoms.

• •Hypersensitivity to Vorisetin or any component of the formulation
• •Concomitant use with Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of discontinuing an MAOI
• •Concomitant use with Pimozide

Store below 30°C in a dry place, away from light. Keep out of reach of children.

Symptoms of overdose include drowsiness, nausea, vomiting, tachycardia, tremor, agitation, and rarely, seizures or serotonin syndrome. Treatment is supportive and symptomatic; maintain airway, monitor cardiac and vital signs. Activated charcoal may be considered. No specific antidote.

Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Vorisetin is excreted in breast milk; caution should be exercised when administered to a nursing mother.